“the eyes are an extension of the brain, or more technically, the retinas are truly brain tissue but merely reside outside the cranial vault”
Our Solution
Our solution is a hardware device and an integrated software platform capable of identifying ocular biomarker for Alzheimer’s Disease in a primary-care setting. It enables operators with minimal training to evaluate whether a patient is currently suffering from early stage Alzheimer’s disease. The technology uses a combination of commodity imaging hardware, computer vision and AI to standardise and stratify the screening of Alzheimer’s Disease.
Hardware
We are developing a retinal imaging headset which:
- does not require a trained operator
- is non-invasive
- gives instant results
AI powered Algorithms
Our algorithms provide a quantitative indication of Alzheimier's Disease progression at the Mild Cognitive Impairment Stage. The technology assists clinicians by providing an orthogonal biomarker modality to inform early-stage diagnosis alongside traditional AD biomarkers.
Platform
Our secure platform enables clinicians and researchers to:
- remotely capture retinal images
- store them securely
- run our diagnostic ML algorithms
- develop their own ML algorithms
